University College London-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2022

  1. Multitarget Hybrid Fasudil Derivatives as a New Approach to the Potential Treatment of Amyotrophic Lateral Sclerosis

    Journal of Medicinal Chemistry, Vol. 65, Núm. 3, pp. 1867-1882

2017

  1. Discovery of the first dual GSK3β inhibitor/Nrf2 inducer. A new multitarget therapeutic strategy for Alzheimer's disease

    Scientific Reports, Vol. 7